First, decide the conclusion you want and then pay bogus scientists $1.6 million to make up the proof

According to a notice in the Federal Register posted
yesterday, the CDC is paying the University of Southern Denmark to conduct a
single-blind clinical trial of the hepatitis B vaccine in newborns in
Guinea-Bissau, a small country in West Africa with exceptionally high rates of
maternal and infant mortality, where nearly one in five people are infected with the
hepatitis B virus.
The CDC is an agency within HHS. The study aims to assess
the optimal timing and delivery of hepatitis B vaccinations, according to the
notice.
‘Appearance of blatant cronyism’
The new study was awarded without any competition from any
other scientists, giving it “the appearance of blatant cronyism,” said Angela
Rasmussen, PhD, a virologist and professor at the University of Saskatchewan.
Although the federal announcement did not include the names
of the researchers, the Danish university’s Bandim Health Project, which has
conducted vaccine research in the developing African country for decades, has acknowledged being
awarded the CDC grant.
The Bandim project leaders have claimed to find
“non-specific effects” from vaccines—some good and some bad—that
they say should change how vaccine
safety studies are conducted.
Their message has resonated with Kennedy, a
long-time anti-vaccine activist.
In June, Kennedy used
a single study by the Bandim group to justify canceling more
than $1 billion in funding for childhood vaccinations in developing countries.
The observational study found an increased risk of death in children who
received a combined vaccine for diphtheria, tetanus and pertussis (DPT) that
hasn’t been used in the United States in three decades.
Scientists say people shouldn’t put too much faith in that
study, which is an outlier and conflicts with hundreds of studies showing that
vaccines are safe and save lives. Researchers and policy makers normally
consider the totality of scientific evidence on vaccines, rather than a single
study, which may be flawed.
























.webp)
















